Skip to main content

Fecal Incontinence clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

    Sorry, in progress, not accepting new patients

    This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphincter injury. Half of the participants will receive iltamiocel (injections with cells) and the other half will receive placebo.

    San Francisco 5391959, California 5332921 and other locations

Last updated: